[go: up one dir, main page]

ES2173638T3 - Esferoides que contienen tiagabina, procedimiento de fabricacion y composiciones farmaceuticas. - Google Patents

Esferoides que contienen tiagabina, procedimiento de fabricacion y composiciones farmaceuticas.

Info

Publication number
ES2173638T3
ES2173638T3 ES98954682T ES98954682T ES2173638T3 ES 2173638 T3 ES2173638 T3 ES 2173638T3 ES 98954682 T ES98954682 T ES 98954682T ES 98954682 T ES98954682 T ES 98954682T ES 2173638 T3 ES2173638 T3 ES 2173638T3
Authority
ES
Spain
Prior art keywords
thiagabine
pharmaceutical compositions
manufacturing procedure
spheroids containing
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98954682T
Other languages
English (en)
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Pascal Suplie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Application granted granted Critical
Publication of ES2173638T3 publication Critical patent/ES2173638T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esferoides que contienen tiagabina como principio activo y que comprenden: - un núcleo y/o una capa que recubre dicho núcleo, que contiene por lo menos un excipiente termoplástico que tiene consistencia pastosa a semisólida a una temperatura de aproximadamente 20ºC, y cuyo punto de fusión está entre aproximadamente 25ºC y 100ºC, recubierto con - una película flexible y deformable, basada en un material polimérico, en particular una película cuya temperatura de transición al cristal es inferior a 30ºC aproximadamente, lo que asegura la protección o el enmascaramiento del sabor, o la liberación modificada y controlada de la tiagabina.
ES98954682T 1997-11-21 1998-11-19 Esferoides que contienen tiagabina, procedimiento de fabricacion y composiciones farmaceuticas. Expired - Lifetime ES2173638T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714635A FR2771292B1 (fr) 1997-11-21 1997-11-21 Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
ES2173638T3 true ES2173638T3 (es) 2002-10-16

Family

ID=9513639

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98954682T Expired - Lifetime ES2173638T3 (es) 1997-11-21 1998-11-19 Esferoides que contienen tiagabina, procedimiento de fabricacion y composiciones farmaceuticas.

Country Status (12)

Country Link
US (1) US6139877A (es)
EP (1) EP1032391B1 (es)
JP (1) JP2001523719A (es)
AT (1) ATE217525T1 (es)
AU (1) AU1170399A (es)
DE (1) DE69805433T2 (es)
DK (1) DK1032391T3 (es)
ES (1) ES2173638T3 (es)
FR (1) FR2771292B1 (es)
PT (1) PT1032391E (es)
WO (1) WO1999026626A1 (es)
ZA (1) ZA9810630B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
FR2771291B1 (fr) * 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
PT1165042E (pt) 1999-04-06 2005-06-30 Ethypharm Sa Suspensao farmaceutica bebivel de ibuprofeno
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
ES2221804B1 (es) * 2003-06-18 2006-04-01 Lipofoods, S.L. Microcapsulas para la administracion de ingredientes activos.
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
CN102958515A (zh) 2009-12-02 2013-03-06 阿普塔利斯制药有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
AR079862A1 (es) * 2010-01-08 2012-02-22 Eurand Inc Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
AU2012214553B2 (en) 2011-02-11 2015-07-09 Sociétés des Produits Nestlé S.A. Multiparticulate L-menthol formulations and related methods
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
HUE042996T2 (hu) 2013-04-23 2019-07-29 Zx Pharma Llc Bélben oldódó bevonatú, fehérjetartalmú alapbevonattal ellátott, több részecskét tartalmazó készítmény

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
JPS62153213A (ja) * 1985-12-26 1987-07-08 Dai Ichi Seiyaku Co Ltd 腸溶性粒状物
CA1338596C (en) * 1988-09-27 1996-09-17 Hiroyoshi Koyama Granules having core and their production
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
US5484608A (en) * 1994-03-28 1996-01-16 Pharmavene, Inc. Sustained-release drug delivery system
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5750140A (en) * 1994-05-20 1998-05-12 Novo Nordisk A/S Transdermal delivery of tiagabine
US5866590A (en) * 1995-05-05 1999-02-02 Novo Nordisk A/S Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
CA2284000C (en) * 1997-03-12 2012-01-03 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine

Also Published As

Publication number Publication date
ZA9810630B (en) 1999-05-24
ATE217525T1 (de) 2002-06-15
FR2771292B1 (fr) 2000-02-18
EP1032391B1 (en) 2002-05-15
JP2001523719A (ja) 2001-11-27
DE69805433D1 (de) 2002-06-20
EP1032391A1 (en) 2000-09-06
US6139877A (en) 2000-10-31
WO1999026626A1 (en) 1999-06-03
DE69805433T2 (de) 2002-11-07
FR2771292A1 (fr) 1999-05-28
DK1032391T3 (da) 2002-09-09
AU1170399A (en) 1999-06-15
PT1032391E (pt) 2002-09-30

Similar Documents

Publication Publication Date Title
ES2173638T3 (es) Esferoides que contienen tiagabina, procedimiento de fabricacion y composiciones farmaceuticas.
BRPI0316616B8 (pt) emplastro térmico com efeito térmico suficiente que torna a sensação agradável mais duradoura e irritação residual mais reduzida
BR9916560A (pt) Estrutura absorvente composta, método para formar a mesma, e produto absorvente descartável
CL2003002767A1 (es) Composicion oral que comprende una pelicula que contiene un material funcional, en un vehiculo, util para el cuidado oral.
ES2167727T3 (es) Microparticulas de gel compuesto como vectores de principios activos.
ES2145836T3 (es) Copolimeros elastomericos termoplasticos injertados de silicona, y composiciones que los contienen para el cuidado del pelo y la piel.
BR0110738A (pt) Combinações de agentes protetores de plantas com materiais veìculos orgânicos ou inorgânicos
AR033761A1 (es) Banda adhesiva
ES2091363T3 (es) Compuesto farmaceutico de liberacion controlada con propiedades bioadhesivas.
BR0317682A (pt) Composição farmacêutica de liberação modificada
ES2093420T3 (es) Un vendaje absorbente de herida.
GT199900203A (es) Composiciones de celecoxib.
BR9910113A (pt) Composições oftálmicas que se transformam em gel, contendo goma xantano
CO5060475A1 (es) Envoltura termica elastica desechable para el cuerpo metodo para su fabricacion
BR9909351A (pt) Composição cosmética
AR002266A1 (es) Composicion farmaceutica de gelatina blanda o forma de dosis que la incluye
BR0213588A (pt) Formas de dosagens de liberação modificada
DK0644746T3 (da) Anvendelse af glycerin til moderering af transdermal lægemiddelafgivelse
BR0115993A (pt) Camada de cobertura impermeável à subst ncia ativa, que contém agentes de absorção e formadores de canais, ou camada de proteção destacável de um sistema terapêutico transdérmico
SV1998000068A (es) Dispositivo para el suministro de plaguicidas agricolas
ES2143291T3 (es) Composicion de maquillaje o de tratamiento, sin transferencia, conteniendo un organopolisiloxano solido elastomero y una fase grasa.
ECSP055534A (es) Artículo absorbente que contiene una composición para el cuidado de la piel
AR021371A1 (es) Aposito
ES2140952T3 (es) Composiciones para el maquillaje de los ojos.
ES2176785T3 (es) Procedimiento de fabricacion de una composicion farmaceutica con liberacion modificada de principio activo, que comprende una matriz.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1032391

Country of ref document: ES